Ann Clin Lab Sci

1. KRZESAJ PK, Seydafkan S, Miller AI, Chen HT, et al
   HDM-2-Targeting Peptide PNC-27 Kills Cervical Cancer Cells but not Normal Cervical Cells.
   Ann Clin Lab Sci. 2025;55:347-353.
   

   >> Share

   
   

   
   Biomed Eng Online

2. LI M, Wu X, Liu X, Wen M, et al
   Effects of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) on survival benefits and poor prognostic factors in patients with cervical cancer.
   Biomed Eng Online. 2025;24:96.
   

   >> Share

   
   

   
   Biomol Biomed

3. MATEEN AZHAR M, Maqbool T, Ali F, Altaf A, et al
   Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells.
   Biomol Biomed. 2025;25:1751-1764.
   

   >> Share

   
   

   
   BMC Cancer

4. TUPA F, Ruwaichi T, Luoga P, Mwaiselage J, et al
   Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer: a case study from ocean road cancer institute, Tanzania.
   BMC Cancer. 2025;25:1259.
   

   >> Share

   
   
5. ZHANG B, Li Z, Yang Z, Yin Y, et al
   Downregulation of PGK1 promotes lipid peroxidation and suppresses proliferation in cervical cancer revealed by liquid-liquid phase separation-related gene signature.
   BMC Cancer. 2025;25:1269.
   

   >> Share

   
   
6. HAN S, Qin Y, He Y, Li M, et al
   LncRNA SNHG15 targets miR-200a-3p affects the proliferation, apoptosis, migration, and invasion of cervical cancer cells.
   BMC Cancer. 2025;25:1279.
   

   >> Share

   
   

   
   BMC Public Health

7. GULLE BT, Tozduman B, Oren Celik MM
   Determinants of cancer screening participation in Turkiye: a nationwide study of demographic, socioeconomic, and lifestyle factors.
   BMC Public Health. 2025;25:2637.
   

   >> Share

   
   
8. MHANGO P, Kumitawa A, Malata MP, Tang JH, et al
   Acceptability, feasibility and appropriateness of integrating HPV self-sampling for cervical cancer screening into voluntary family planning services in Malawi.
   BMC Public Health. 2025;25:2615.
   

   >> Share

   
   

   
   Brachytherapy

9. OKUMA K, Murakami N, Inaba K, Kashihara T, et al
   Gel spacer-assisted salvage brachytherapy for pelvic recurrence after definitive chemoradiotherapy in cervical cancer: A single-institution retrospective study.
   Brachytherapy. 2025 Aug 5:S1538-4721(25)00246.
   

   >> Share

   
   
10. CHAN K, Ballantyne H, Liu ZA, Milosevic M, et al
    Intra-operative process efficiency for in-room MRI-guided combined intracavitary/interstitial brachytherapy for cervical cancer.
    Brachytherapy. 2025 Jul 31:S1538-4721(25)00124.
    

    >> Share

    
    

    
    Cancer Causes Control

11. POCOBELLI G, Lykken J, Haas JS, Tiro J, et al
    Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems.
    Cancer Causes Control. 2025 Aug 6. doi: 10.1007/s10552-025-02039.
    

    >> Share

    
    

    
    Cell Signal

12. WANG J, Zhang J, Wang T, Rong C, et al
    Notch signaling pathway in cervical cancer: From molecular mechanism to therapeutic potential.
    Cell Signal. 2025;135:112042.
    

    >> Share

    
    

    
    Chem Biodivers

13. YANG M, Lu Y, Han L, He Z, et al
    A Novel Endophytic Fungus, Alternaria semiverrucosa, and Its Ethyl Acetate Extract Inhibit the Proliferation, Migration, and Invasion of Cervical Cancer Cells.
    Chem Biodivers. 2025 Aug 6:e00945. doi: 10.1002/cbdv.202500945.
    

    >> Share

    
    

    
    Comput Biol Chem

14. CHAND T, Vaishanavaa P, Dubey AK, Misra G, et al
    Identification of hub genes as potential diagnostic biomarkers for cervical cancer: A bioinformatic approach.
    Comput Biol Chem. 2025;119:108605.
    

    >> Share

    
    

    
    Cureus

15. WYER A, Louis M, Okunlola OI, Richardson R, et al
    Enterocutaneous Fistula: A Challenging Complication in Cervical Cancer Management.
    Cureus. 2025;17:e87475.
    

    >> Share

    
    
16. CHARTIAN MS, Chellani G, Singh M, Dhankar N, et al
    Interobserver Variability and Comparison of Liquid-Based Cytology Versus Conventional Pap Smear for Cervical Cancer Screening in a High-Risk Population.
    Cureus. 2025;17:e87210.
    

    >> Share

    
    

    
    Diagn Cytopathol

17. FAN R, Song S, Shi H, Zhang X, et al
    A Retrospective Analysis of 1151 Chinese Women With Atypical Glandular Cells: Impact of High-Risk Human Papilloma Virus Status and Age on Cervical and Endometrial Neoplasia Risk.
    Diagn Cytopathol. 2025 Jun 9. doi: 10.1002/dc.25495.
    

    >> Share

    
    

    
    Discov Oncol

18. XIAO WQ, Lee DH, Kim H, Zhang HN, et al
    Ethyl beta-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.
    Discov Oncol. 2025;16:1498.
    

    >> Share

    
    

    
    Epidemiol Serv Saude

19. SILVA GO, Braga YS, Reis IF, Alessio Junior LE, et al
    Cervical cancer mortality: descriptive study and time series analysis, Mato Grosso, 2013-2022.
    Epidemiol Serv Saude. 2025;34:e20240503.
    

    >> Share

    
    

    
    Eur J Pharm Biopharm

20. ALVAREZ-QUEZADA OA, Espino-Nunez YE, Valencia-Gomez LE, Martel-Estrada SA, et al
    Controlled release of curcumin and gemcitabine from mucoadhesive chitosan-gelatin polymeric ovules: Cytotoxic effects on cervical cancer cells.
    Eur J Pharm Biopharm. 2025 Aug 1:114834. doi: 10.1016/j.ejpb.2025.114834.
    

    >> Share

    
    

    
    Front Immunol

21. LI Y, Lin Z, Lin G, Zhao Z, et al
    Revolutionizing cervical cancer treatment: single-cell sequencing of TSPAN1+ tumor EPCs and immune checkpoints to assess drug sensitivity and optimize therapy.
    Front Immunol. 2025;16:1574174.
    

    >> Share

    
    
22. CHEN MM, Zhang BQ, Luan YS, Sun GL, et al
    The diagnostic of PAX1 gene methylation in cervical lesions and its role in the triage of non-16/18 HR-HPV positive.
    Front Immunol. 2025;16:1634297.
    

    >> Share

    
    
23. TAN X, Yang J, Li Y, Wan K, et al
    Development of Z(HPV16E7)- granzyme B immunoaffitoxin: dual mechanisms targeting hpv16-positive cervical cancer through epithelial-mesenchymal transition inhibition and cell death.
    Front Immunol. 2025;16:1616715.
    

    >> Share

    
    
24. YIN B, Chen C, Huang B, Ding J, et al
    Oncogenic CMTM6 drives M2a macrophages formation and fuels cervical cancer progression.
    Front Immunol. 2025;16:1621816.
    

    >> Share

    
    

    
    Front Oncol

25. FOLINO G, Zent I, Eason L, Murugan V, et al
    Temporal trends of cervical cancer demographics: a CDC WONDER database study.
    Front Oncol. 2025;15:1567305.
    

    >> Share

    
    
26. SUN H, Wang H, Liu Y, Xu H, et al
    Comparison of the SureX((R)) HPV genotyping test with the Digene Hybrid Capture((R)) 2 test in cervical cancer screening.
    Front Oncol. 2025;15:1627935.
    

    >> Share

    
    
27. TEIXEIRA AL, Dias F, Gil da Costa RM
    Editorial: Exploring HPV's role in genitourinary cancers beyond cervical cancer.
    Front Oncol. 2025;15:1658619.
    

    >> Share

    
    

    
    Gynecol Oncol

28. WANG Y, Jia Z, Jiao J, Yue X, et al
    Analysis of the use of prophylactic ureteral stents in preventing iatrogenic ureteral injury during radical hysterectomy for cervical Cancer.
    Gynecol Oncol. 2025;200:155-160.
    

    >> Share

    
    

    
    Hereditas

29. YANG Y, Guo Z
    Prognostic value of Linc00662/miR-16-5p/FASN in cervical cancer and regulation of tumor progression.
    Hereditas. 2025;162:151.
    

    >> Share

    
    

    
    Int J Behav Med

30. CHAN DNS, Choi KC, Lee PPK, So WKW, et al
    The Effects of Motivational Interviewing on Promoting Human Papillomavirus Vaccination Initiation and Completion Among South Asian Mother/Daughter Dyads: A Pilot Randomised Controlled Trial.
    Int J Behav Med. 2025;32:574-585.
    

    >> Share

    
    

    
    Int J Biol Macromol

31. WANG H, Shang K, Tang K, Duan Z, et al
    Development of palmatine chloride-loaded chitosan nanoparticles for enhanced and safe cervical cancer therapy.
    Int J Biol Macromol. 2025 Aug 4:146579. doi: 10.1016/j.ijbiomac.2025.146579.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

32. HUANG W, Fang X, Ou X, Chen L, et al
    Postoperative Adjuvant Treatments for Cervical Cancer: A Network Meta-analysis.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06039.
    

    >> Share

    
    

    
    J Cell Mol Med

33. ZHONG L, Li J, Zhong J, Zhang Y, et al
    IFI16 Induced by p53 Activates the NF-kappaB Pathway to Counteract Cisplatin-Induced Apoptosis in Cervical Cancer Cells.
    J Cell Mol Med. 2025;29:e70728.
    

    >> Share

    
    

    
    J Cyst Fibros

34. STEPHENSON AL, Sharpe I, Sykes J, Ma X, et al
    Primary care physician involvement increases likelihood of cancer screening in people with cystic fibrosis: A population-based study from Ontario, Canada.
    J Cyst Fibros. 2025;24:698-703.
    

    >> Share

    
    

    
    J Educ Health Promot

35. CHADHA L, Sharma P, Bhide N, Arya I, et al
    Empowering perimenopausal women: A critical examination of opportunistic teaching on cervical cancer awareness.
    J Educ Health Promot. 2025;14:268.
    

    >> Share

    
    

    
    J Inflamm Res

36. WANG J, Chen Z, Guan M, Ma Z, et al
    The Persistent Threat of Chronic Inflammation on the Mortality Among Cervical Cancer Survivors: A Mendelian Randomization and Machine Learning Analysis Using UK Biobank and Chinese Cohort Data.
    J Inflamm Res. 2025;18:10267-10282.
    

    >> Share

    
    

    
    J Int Med Res

37. SUSETIATI DA, Pudjiati SR, Wirohadidjojo YW, Chandra LA, et al
    Effectiveness of Lactobacillus therapy in women with cervical human papillomavirus infection: A systematic review and meta-analysis.
    J Int Med Res. 2025;53:3000605251363006.
    

    >> Share

    
    

    
    J Med Life

38. SAVELIEV GM, Varlas VN, Piron-Dumitrascu M, Suciu N, et al
    Prioritizing the risk of cervical cancer: findings from the SCCUT Multicentre Initiative.
    J Med Life. 2025;18:590-593.
    

    >> Share

    
    

    
    J Med Virol

39. XU L, Ma C, Cuschieri K, Bonde J, et al
    Clinical Validation of the Venus HPV Full-Genotyping Assay for Cervical Cancer Screening in the VALGENT-4 Framework.
    J Med Virol. 2025;97:e70527.
    

    >> Share

    
    

    
    J Pathol Clin Res

40. LI L, Yao M, Li L, Shi S, et al
    Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome-wide mutation analysis.
    J Pathol Clin Res. 2025;11:e70040.
    

    >> Share

    
    

    
    J Robot Surg

41. PAZZAGLIA E, Pasquini P, Jamaer E, Traen K, et al
    Pioneering telesurgery in gynecology: the first European case of total hysterectomy.
    J Robot Surg. 2025;19:460.
    

    >> Share

    
    

    
    J Surg Case Rep

42. SULEJMANI H, Vasilevski F, Krsteska B, Tanevska Zrmanovska A, et al
    Radiation-induced rectal leiomyosarcoma in a cervical cancer survivor: a case report.
    J Surg Case Rep. 2025;2025:rjaf609.
    

    >> Share

    
    

    
    J Transl Med

43. TSEMENTZI D, Meador R, Eng T, Shelton J, et al
    Associations among HPV persistence, the vaginal microbiome, and cervical cancer recurrence.
    J Transl Med. 2025;23:858.
    

    >> Share

    
    
44. CHEN S, Dai H, Hu S, Gao T, et al
    Novel triple-target panels utilizing methylation-sensitive restriction enzyme-based quantitative PCR for detecting advanced cervical precancers and cancers among high-risk HPV-positive women.
    J Transl Med. 2025;23:857.
    

    >> Share

    
    

    
    JAMA Netw Open

45. AL-BITAR A, Kouli A, Janoud O, Harb A, et al
    Breast and Cervical Cancer Gaps in Displaced Lebanese Women in Syria.
    JAMA Netw Open. 2025;8:e2525652.
    

    >> Share

    
    

    
    JCO Clin Cancer Inform

46. NGUYEN AM, Waldron-Corredor A, Liu FY, Yun X, et al
    Breast, Cervical, and Colorectal Cancer Screening Among New Jersey Medicaid Enrollees: 2017-2022.
    JCO Clin Cancer Inform. 2025;9:e2500055.
    

    >> Share

    
    

    
    Klin Onkol

47. SOROKIN P, Kulikova S, Stepanyan A, Davtyan H, et al
    Total mesometrial resection for the treatment of cervical cancer - an exploratory study of feasibility, safety and oncological outcomes in developing countries.
    Klin Onkol. 2025;38:201-208.
    

    >> Share

    
    
48. SOUMAROVA R, Havlik J
    Current complex treatment for cervical cancer.
    Klin Onkol. 2025;38:185-191.
    

    >> Share

    
    

    
    Lancet

49. LIU T, Lu D, Wu X
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply.
    Lancet. 2025;406:446.
    

    >> Share

    
    
50. CHENG C
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial.
    Lancet. 2025;406:445.
    

    >> Share

    
    
51. HUANG L, We Y, Chen F
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial.
    Lancet. 2025;406:445-446.
    

    >> Share

    
    

    
    Medicine (Baltimore)

52. ZHANG X, Xu J
    Alveolar rhabdomyosarcoma of cervix: A case report.
    Medicine (Baltimore). 2025;104:e43675.
    

    >> Share

    
    

    
    Microbiol Spectr

53. HUANG S, Gentil LG, Schmidt C, Cullum R, et al
    Comparative clinical performance of Alinity m HR HPV, cobas 4800 HPV, and cobas 6800 HPV for cervical cancer screening.
    Microbiol Spectr. 2025 Aug 6:e0058925. doi: 10.1128/spectrum.00589.
    

    >> Share

    
    

    
    Nat Commun

54. BARRA MJ, Wilkinson AF, Ma AE, Goli K, et al
    One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique.
    Nat Commun. 2025;16:7295.
    

    >> Share

    
    

    
    NPJ Digit Med

55. WANG W, Yang G, Liu Y, Wei L, et al
    Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
    NPJ Digit Med. 2025;8:503.
    

    >> Share

    
    

    
    Obstet Gynecol

56. LI R, Sun LF, Li RZ, Wang ZY, et al
    Incidence of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Cancer or Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2025 Aug 7. doi: 10.1097/AOG.0000000000006026.
    

    >> Share

    
    

    
    Obstet Gynecol Clin North Am

57. DE LA PENA R, Peterson E
    Common Cancers in the Pregnant Patient.
    Obstet Gynecol Clin North Am. 2025;52:507-517.
    

    >> Share

    
    

    
    Oncol Rep

58. LI X, Zhou M, Yu J, Yu S, et al
    Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review).
    Oncol Rep. 2025;54:131.
    

    >> Share

    
    

    
    Pathobiology

59. AL HINAI F, Al Shamsi R, Al Husaini S, Al Rashdi A, et al
    The Role of Cytokeratin 7 and Cytokeratin 19 Immunohistochemistry in the Evaluation of Human Papillomavirus-Induced Cervical Squamous Precursor Epithelial Lesions.
    Pathobiology. 2025;92:216-223.
    

    >> Share

    
    

    
    Photodiagnosis Photodyn Ther

60. LI J, Huang Y, Tao J, Yang H, et al
    Evaluation of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for cervical intraepithelial neoplasia with human papillomavirus (HPV) infection: a retrospective comparative study versus loop electrosurgical excision procedure (LEE
    Photodiagnosis Photodyn Ther. 2025;54:104697.
    

    >> Share

    
    
61. CHEN R, Xu J, Ye C, Lu L, et al
    Efficacy of 5-aminolevulinic acid photodynamic therapy versus observation for cervical low-grade squamous intraepithelial lesion with type 3 transformation zone.
    Photodiagnosis Photodyn Ther. 2025;54:104679.
    

    >> Share

    
    

    
    Radiography (Lond)

62. LOPEZ-UBEDA P, Martin-Noguerol T, Luna A
    Natural language processing evaluation of trends in cervical cancer incidence in radiology reports: A ten-year survey.
    Radiography (Lond). 2025 Aug 4:103117. doi: 10.1016/j.radi.2025.103117.
    

    >> Share

    
    

    
    Res Sq

63. MANGA S, Yuanfan Y, Scarinci I, Nulah K, et al
    Comparing a "See-and-Treat" HPV-Based to VIA-Based Cervical Cancer Prevention Strategies Among Women Living with HIV in Cameroon: A Pilot Study.
    Res Sq [Preprint]. 2025 Jul 28:rs.3.rs-7097928. doi: 10.21203/rs.3.rs-7097928.
    

    >> Share

    
    

    
    Rev Bras Epidemiol

64. LIMA BG, Barros MBA
    Prevalence and social inequalities in the use of cancer screening tests in Campinas, Brazil (ISACamp 2014/15).
    Rev Bras Epidemiol. 2025;28:e250043.
    

    >> Share

    
    

    
    Sci Rep

65. LIANG X, Zeng XT, Hong ZL, Lin XY, et al
    Perfluorobutane CEUS for early-stage cervical lymphoma: diagnostic value of the postvascular phase starfield sign.
    Sci Rep. 2025;15:28486.
    

    >> Share

    
    
66. YANG WJ, Lee SH, Kim YJ, Kim KG, et al
    Comparison of performance of cervical cancer grading based on acetowhite areas.
    Sci Rep. 2025;15:28258.
    

    >> Share

    
    
67. SHI R, Qi W, Wang Z, Cai J, et al
    High-risk human papillomavirus genotype distribution and attribution to cervical lesions in a Shanxi Province screening population.
    Sci Rep. 2025;15:28217.
    

    >> Share

    
    
68. DE SOUZA ATB, de Sousa Santos DL, Medeiros FS, de Carvalho KTC, et al
    Comparison of IL-10 gene promoter polymorphisms and haplotypes between high-grade squamous intraepithelial lesions or cervical cancer and negative cervical cytology.
    Sci Rep. 2025;15:28330.
    

    >> Share

    
    

    
    Semin Reprod Med

69. SELLAMI I, Sais E, Souare F, Becquart C, et al
    Fertility Preservation in Women with Cervical Cancer.
    Semin Reprod Med. 2025 Aug 1. doi: 10.1055/s-0045-1810055.
    

    >> Share

    
    

    
    Stud Health Technol Inform

70. CHUKWUEMEKA I, Sudeshna D, Yuting G, Swati R, et al
    Bridging AI, NLP, and Digital Health: A Bi-Directional Learning Experience at Emory University.
    Stud Health Technol Inform. 2025;329:1822-1823.
    

    >> Share

    
    
71. TAJIRIAN T, Adams N, Nicolle J, DeLasa C, et al
    Digitally Empowered: Boosting Cervical and Breast Cancer Screening for Patients with Severe Mental Illness Through Smart EHR Solutions.
    Stud Health Technol Inform. 2025;329:367-370.
    

    >> Share

    
    

    
    Virol J

72. JING Y, Chen J, Lin F, Huang X, et al
    Multiple high-risk human papillomavirus infections exacerbate cervical lesion risk: epidemiological evidence from suining, Sichuan.
    Virol J. 2025;22:268.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share